Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 17 results found. Search for [ Saridon ]

Results 1 to 17 of 17
PB Jayakumar
New Delhi, September 18, 2020
Nandini Piramal has taken the group's pharma OTC business from Rs 127 cr to Rs 418 cr


BusinessToday.In
April 23, 2019
Piramal Gorup Chairman Ajay Piramal who began investing in Shriram group in 2013 has not been able to realise his aspirations in the financial services sector.


BusinessToday.In
February 22, 2019
The Kotak Mahindra Bank share price slipped in trade today amid reports that ING group was looking to sell its stake through block deals.


BusinessToday.In
February 22, 2019
Piramal Enterprises share price rose nearly 2% to 2,284 level compared to the previous close of 2,240.15 on the BSE. Piramal Enterprises share price has been gaining for the last five days and risen 4.41% during the period.


PTI
February 21, 2019



PTI
January 17, 2019



BusinessToday.In
New Delhi, September 17, 2018
The decision was taken after drug makers filed a petition, saying that these drugs were being manufactured since 1988. They cited the SC's earlier relief to 15 manufacturers on the bases of the similar grounds, saying that they should also be exempted from the ban.


E Kumar Sharma
New Delhi, September 13, 2018
As the industry is trying to digest the development, not totally unexpected though, there are fresh concerns on what could come next as the ministry-appointed Prof Kokate Expert committee had discussed banning many more FDC drugs.


BusinessToday.In
New Delhi, September 13, 2018
India reportedly boasts around 2,000 FDCs, four times more that what's available in the US.


BusinessToday.In
New Delhi, September 13, 2018
The FDC medicines are two or more drugs contained in a single dosage form. The health ministry says it took the decision to ban these drugs after the Drugs Technical Advisory Board suggested these drugs might pose a risk to human beings.


PTI
December 16, 2017



PTI
December 15, 2017



PB Jayakumar
New Delhi, December 5, 2017
The OTC business of Piramal, already among the top five OTC specialists in the Rs 20,000 crore market, had revenues of Rs 375 crore in 2016-17, a jump of 44 per cent compared to the Rs 261 crore it posted in the previous year.


By P.B. Jayakumar
Delhi, July 27, 2016
But nothing sticks in public memory more than his most recent avatar - Ajay Piramal, the investor. The contrarian, who is placing big bets on businesses ranging from financial services to healthcare on one hand, and drug discovery and realty on the other.


Ajita Shashidhar
May 2, 2014
The company recently put up a video on YouTube which is about its recently launched ovulation kit. The video, claims, Rajadnye got more than 500,000  hits within the first few weeks of launch.


Geetanjali Shukla
November 11, 2011
Ajay Gopikrishna Piramal has not done much with the cash pile of he got as part-payment, when he sold his company's formulations business to the US-based Abbott Lab. While one wonders reasons behind the inaction, Business Today learns that he has set up three strategy groups to look for business opportunities.


By Babar Zaidi
August 17, 2007
Which of the following common investment blunders have you committed? Avoid them and see your returns improve.


PAGES 1 OF 1